We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. Find out more P557 Antibody and cell-mediated immune response to whole virion and split virion influenza vaccine in patients with inflammatory bowel disease on maintenance immunosuppressive and biological therapy | Journal of Crohn's and Colitis | Oxford Academic Skip to Main Content
Oxford University Press
  • Sign In
  • Register
  • Sign In
  • Register
  • Issues
  • More Content
    • Advance articles
    • Editor's Choice
    • Supplements
  • Submit
    • Author Guidelines
    • Submission Site
    • Order Offprints
    • Open Access Options
  • Purchase
  • Advertise
    • Advertising and Corporate Services
    • Advertising
    • Mediakit
    • Reprints and ePrints
    • Sponsored Supplements
    • Branded Books
    • Journals Career Network
  • About
    • About Journal of Crohn's and Colitis
    • About the European Crohn's and Colitis Organisation
    • Editorial Board
    • Alerts
    • Policies
    • Self-Archiving Policy
    • Dispatch Dates
Journal of Crohn's and Colitis
European Crohn?s and Colitis Organisation
  • Issues
  • More Content
    • Advance articles
    • Editor's Choice
    • Supplements
  • Submit
    • Author Guidelines
    • Submission Site
    • Order Offprints
    • Open Access Options
  • Purchase
  • Advertise
    • Advertising and Corporate Services
    • Advertising
    • Mediakit
    • Reprints and ePrints
    • Sponsored Supplements
    • Branded Books
    • Journals Career Network
  • About
    • About Journal of Crohn's and Colitis
    • About the European Crohn's and Colitis Organisation
    • Editorial Board
    • Alerts
    • Policies
    • Self-Archiving Policy
    • Dispatch Dates
Close
Advanced Search
Article navigation
Issue Cover
Volume 8
Issue Supplement_1
February 2014
  • < Previous
  • Next >

P557 Antibody and cell-mediated immune response to whole virion and split virion influenza vaccine in patients with inflammatory bowel disease on maintenance immunosuppressive and biological therapy

A. Balint
Search for other works by this author on:
Oxford Academic
PubMed
Google Scholar
A. Balint
K. Farkas
Search for other works by this author on:
Oxford Academic
PubMed
Google Scholar
K. Farkas
É. Pallagi-Kunstár
Search for other works by this author on:
Oxford Academic
PubMed
Google Scholar
É. Pallagi-Kunstár
G. Terhes
Search for other works by this author on:
Oxford Academic
PubMed
Google Scholar
G. Terhes
E. Urbán
Search for other works by this author on:
Oxford Academic
PubMed
Google Scholar
E. Urbán
M. Szucs
Search for other works by this author on:
Oxford Academic
PubMed
Google Scholar
M. Szucs
T. Nyári
Search for other works by this author on:
Oxford Academic
PubMed
Google Scholar
T. Nyári
Z. Bata
Search for other works by this author on:
Oxford Academic
PubMed
Google Scholar
Z. Bata
F. Nagy
Search for other works by this author on:
Oxford Academic
PubMed
Google Scholar
F. Nagy
Z. Szepes
Search for other works by this author on:
Oxford Academic
PubMed
Google Scholar
Z. Szepes
... Show more
P. Miheller
Search for other works by this author on:
Oxford Academic
PubMed
Google Scholar
P. Miheller
K. Lorinczy
Search for other works by this author on:
Oxford Academic
PubMed
Google Scholar
K. Lorinczy
P.L. Lakatos
Search for other works by this author on:
Oxford Academic
PubMed
Google Scholar
P.L. Lakatos
B. Lovász
Search for other works by this author on:
Oxford Academic
PubMed
Google Scholar
B. Lovász
T. Szamosi
Search for other works by this author on:
Oxford Academic
PubMed
Google Scholar
T. Szamosi
A. Kulcsár
Search for other works by this author on:
Oxford Academic
PubMed
Google Scholar
A. Kulcsár
A. Berényi
Search for other works by this author on:
Oxford Academic
PubMed
Google Scholar
A. Berényi
D. Torocsik
Search for other works by this author on:
Oxford Academic
PubMed
Google Scholar
D. Torocsik
T. Daróczi
Search for other works by this author on:
Oxford Academic
PubMed
Google Scholar
T. Daróczi
Z. Saródi
Search for other works by this author on:
Oxford Academic
PubMed
Google Scholar
Z. Saródi
T. Wittmann
Search for other works by this author on:
Oxford Academic
PubMed
Google Scholar
T. Wittmann
T. Molnár
Search for other works by this author on:
Oxford Academic
PubMed
Google Scholar
T. Molnár
Journal of Crohn's and Colitis, Volume 8, Issue Supplement_1, 1 February 2014, Pages S300, https://doi.org/10.1016/S1873-9946(14)60677-2
Published:
01 February 2014
  • Split View
  • Views
    • Article contents
    • Figures & tables
    • Video
    • Audio
    • Supplementary Data
  • PDF
  • Cite
    Citation

    A. Balint, K. Farkas, É. Pallagi-Kunstár, G. Terhes, E. Urbán, M. Szucs, T. Nyári, Z. Bata, F. Nagy, Z. Szepes, P. Miheller, K. Lorinczy, P.L. Lakatos, B. Lovász, T. Szamosi, A. Kulcsár, A. Berényi, D. Torocsik, T. Daróczi, Z. Saródi, T. Wittmann, T. Molnár; P557 Antibody and cell-mediated immune response to whole virion and split virion influenza vaccine in patients with inflammatory bowel disease on maintenance immunosuppressive and biological therapy, Journal of Crohn's and Colitis, Volume 8, Issue Supplement_1, 1 February 2014, Pages S300, https://doi.org/10.1016/S1873-9946(14)60677-2

    Download citation file:

    • RIS (Zotero)
    • EndNote
    • BibTex
    • Medlars
    • ProCite
    • RefWorks
    • Reference Manager

    © 2018 Oxford University Press

    Close
  • Permissions
  • Share
    • Email
    • Twitter
    • Facebook
  • Sign In
  • Register
Close
Advanced Search
This content is only available as a PDF.
© 2014 European Crohn's and Colitis Organisation
Topic:
  • immunosuppressive agents
  • inflammatory bowel disease
  • biological therapy
  • influenza virus vaccine
  • virion
  • antibodies
  • immune response, cell-mediated
Issue Section:
Clinical: Therapy & observation
Download all figures
96 Views
0 Citations
View Metrics
×

Email alerts

New issue alert
Advance article alerts
Article activity alert
Subject alert
Receive exclusive offers and updates from Oxford Academic

More on this topic

The Long-Term Predictive Properties of the Paris Classification in Paediatric Inflammatory Bowel Disease Patients
Dietary Therapy With the Crohn’s Disease Exclusion Diet is a Successful Strategy for Induction of Remission in Children and Adults Failing Biological Therapy
Safety and Efficacy of Granulocyte/Monocyte Apheresis in Steroid-Dependent Active Ulcerative Colitis with Insufficient Response or Intolerance to Immunosuppressants and/or Biologics [the ART Trial]: 12-week Interim Results
Treatment Steps, Surgery, and Hospitalization Rates During the First Year of Follow-up in Patients with Inflammatory Bowel Diseases from the 2011 ECCO-Epicom Inception Cohort

Related articles in

  • Google Scholar

Related articles in PubMed

Umbilical Cord Blood Transplantation Corrects Very Early-Onset Inflammatory Bowel Disease in Chinese Patients With IL10RA-Associated Immune Deficiency.
Influences and Impact of Anxiety and Depression in the Setting of Inflammatory Bowel Disease.
Pediatric Infectious Diseases Meets the Future.

Citing articles via

Google Scholar
CrossRef
  • Latest
  • Most Read
  • Most Cited
Correlation between Endoscopic and Histological Activity in Ulcerative Colitis using Validated Indices
Soluble Mucosal Addressin Cell Adhesion Molecule 1 and Retinoic Acid are Potential Tools for Therapeutic Drug Monitoring in Patients with Inflammatory Bowel Disease Treated with Vedolizumab: A Proof of Concept Study
Therapeutic drug monitoring is more cost-effective than a clinically-based approach in the management of loss of response to infliximab in inflammatory bowel disease: an observational multi-centre study
TNF-anti-TNF Immune Complexes Inhibit IL-12/IL-23 Secretion by Inflammatory Macrophages via an Fc-dependent Mechanism
A phase 2, Randomized, Placebo-controlled Study Evaluating Matrix Metalloproteinase-9 Inhibitor, Andecaliximab, in Patients with Moderately to Severely Active Crohn’s Disease
  • About Journal of Crohn's and Colitis
  • Editorial Board
  • Policies
  • Author Guidelines
  • About ECCO
  • Purchase
  • Recommend to your Library
  • Advertising and Corporate Services
  • Journals Career Network
Journal of Crohn's and Colitis
  • Online ISSN 1876-4479
  • Print ISSN 1873-9946
  • Copyright © 2018 European Crohn's and Colitis Organisation (ECCO) Published by Oxford University Press
  • About Us
  • Contact Us
  • Careers
  • Help
  • Access & Purchase
  • Rights & Permissions
  • Open Access

Connect

  • Join Our Mailing List
  • OUPblog
  • Twitter
  • Facebook
  • YouTube
  • Tumblr

Resources

  • Authors
  • Librarians
  • Societies
  • Sponsors & Advertisers
  • Press & Media
  • Agents

Explore

  • Shop OUP Academic
  • Oxford Dictionaries
  • Oxford Index
  • Epigeum
  • OUP Worldwide
  • University of Oxford

Oxford University Press is a department of the University of Oxford. It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide

Oxford University Press
  • Copyright © 2018 Oxford University Press
  • Cookie Policy
  • Privacy Policy
  • Legal Notice
  • Site Map
  • Accessibility
  • Get Adobe Reader
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close